Join to View Full Profile
750 E Adams StSyracuse, NY 13210
Phone+1 315-464-5540
Dr. Basin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Basin is a urologist based in Syracuse, NY, who completed his urology residency at SUNY Upstate Medical University from 2020 to 2025. His publications cover various topics within urology, including antimicrobial prophylaxis in hypospadias repair, inequities in testicular torsion care, genomic alterations in prostate cancer, efficacy and safety of onabotulinum toxin A in older adults, and disparities in shared decision-making for prostate cancer screening. These works have been published in respected journals such as The Journal of Urology, Journal of Pediatric Surgery, Targeted Oncology, International Urology and Nephrology, and European Urology Focus.
Education & Training
- SUNY Upstate Medical UniversityResidency, Urology, 2020 - 2025
Certifications & Licensure
- CA State Medical License 2025 - 2027
Publications & Presentations
PubMed
- Utility of Preoperative Antimicrobial Prophylaxis in Hypospadias Repair: Results From National Surgical Quality Improvement Program Pediatric Registry.Michael F Basin, Maithili Gopalakrishnan, Nicole Ackerman, Matthew D Mason, Anthony J Tracey
The Journal of Urology. 2025-08-01 - Inequities and Progress in Testicular Torsion Care Following a US News & World Report Metric: A Retrospective Cohort Study.Ahmed Souid, Maithili Gopalakrishnan, Michael Basin, Glenn Cannon, Anthony Tracey
Journal of Pediatric Surgery. 2025-05-01 - Single-Hit and Multi-hit PIK3CA Short Variant Genomic Alterations in Clinically Advanced Prostate Cancer: A Genomic Landscape Study.Michael F Basin, Carla M Miguel, Joseph M Jacob, Hanan Goldberg, Petros Grivas
Targeted Oncology. 2024-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: